Wipro: Organic growth - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Wipro: Organic growth

Apr 17, 2002

Wipro plans to grow organically, literally speaking. The company now plans to tap the bio-informatics markets for future growth. The company recently announced the formation of new business segment, Wipro Healthcare and Life Science. The new business unit will address the requirements of the bio-informatics market, which is estimated to be around US$ 25 bn (Rs 1,252 bn). The market is expected to grow at about 20% annually.In the year 2000 by mapping of the human genome, scientists broke the human genome down into a digital code of 3.1 billion chemical bases. Bioinformatics is a scientific discipline that deals with all aspects of biological information - acquisition, processing, storage, distribution, analysis and interpretation.

Now that biological information, more importantly genetic information, is understood and stored in a digital form, it can be manipulated with the processing power of computers to understand the genes, their effects and more importantly, how these effects can be altered to suit mankind. This calls for combining the tools and techniques of biology, chemistry, computer sciences, information technology and mathematics. This is where the IT services companies come in.

The Applications
Database query tools.
Sequence analysis & Molecular evolution.
Genome mapping & comparison.
Gene Identification.
Structure Prediction.
Molecular Modeling & Simulation.

Coming to the possibilities in business, the first application could be medicine. Deeper understanding of diseases using bio-informatics would help to eradicate the diseases. But after this, the possibilities are limitless right from designer babies to personalised medicine to clones. Trillions of dollars are for the taking.

However, Wipro’s new business unit will not limit itself to providing bio-informatics solutions to life science companies. The division also plans to offer solutions to hospitals and health insurance companies and IT solutions to medical and analytical devices companies. Healthcare has been the vertical IT services companies have been looking at for growth lately. Infosys recently bagged a project from The National Health Services (NHS) UK. (Read more).

Wipro is the latest to join the bioinformatics bandwagon. Satyam is already in a tie up with Center For Cellular and Molecular Biology (CCMB) and TCS has expressed interest to tap the emerging business potential from bio-informatics. Wipro has an added advantage in terms of its relationship with companies like GE Medical Systems.

At the current market price of Rs 1,780, the stock is trading at a P/E multiple of 52x its FY02 estimated earnings. We expected Wipro’s book value to be Rs 118 at the close of fiscal 02. Thus, significant growth expectations have been factored into the stock price. However, considering the fact that US economy expected to turn around in the near future, Wipro will as usual, lead the pack when the prospects for the sector brighten. The stock for the past 52-week has traded in a P/E band of 26x to 52x (Rs 815 to Rs 1,985). Thus, the element of risk is very high.

Equitymaster requests your view! Post a comment on "Wipro: Organic growth". Click here!


More Views on News

WIPRO 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of WIPRO for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of WIPRO. Also includes updates on the valuation of WIPRO.

Wipro Delivers Its 'Best Ever' Quarter Results. Stock Soars 12% in 3 Days (Views On News)

Jul 16, 2021

Shares of Wipro hit a new high of Rs 589 on the BSE today after the company reported a healthy set of June quarter numbers.

WIPRO 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of WIPRO for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of WIPRO. Also includes updates on the valuation of WIPRO.

India's Top 4 IT Companies are Struggling. Here's Why... (Views On News)

Oct 22, 2021

As attrition rates are unbelievably high, top Indian IT companies are going for big-ticket raises, and much more hiring this year.

Infosys had an Exceptional Quarter Buoyed by Huge Deal Wins. Revenue Guidance Boosts Stock (Views On News)

Oct 14, 2021

Infosys raised its forecast for annual revenue growth to 16.5-17.5% from the earlier 14-16%, predicted in July 2021.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Nov 26, 2021 (Close)